Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Engel

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|November 28, 2017
Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 PhenotypeThomas B Casale, Eric D Bateman, Mark Vandewalker, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|December 8, 2019
Is panendoscopy a necessary staging procedure in patients with lacking risk factors and oral squamous cell carcinoma?Karl Metzger, Dominik Horn, Timo Pfeiffer, et al.
Clinical Oral Investigations|March 26, 2024
Second primary squamous cell carcinoma of the oral cavity - a retrospective cohort study of therapeutic procedures and oncological outcomeJulius Moratin, Theresa Maas, Dominik Horn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2015
Shape control and compartmentalization in active colloidal cellsMatthew Spellings, Michael Engel, Daphne Klotsa, et al.
Respiratory Medicine|August 6, 2016
Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic statusHuib A M Kerstjens, Petra Moroni-Zentgraf, Donald P Tashkin, et al.
ACS Nano|October 18, 2022
Quinary, Senary, and Septenary High Entropy Alloy Nanoparticle Catalysts from Core@Shell Nanoparticles and the Significance of Intraparticle HeterogeneitySandra L A Bueno, Alberto Leonardi, Nabojit Kar, et al.
Nature Communications|October 7, 2018
Graphene-enabled and directed nanomaterial placement from solution for large-scale device integrationMichael Engel, Damon B Farmer, Jaione Tirapu Azpiroz, et al.
The Journal of Allergy and Clinical Immunology|February 13, 2017
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthmaStanley J Szefler, Kevin Murphy, Thomas Harper, et al.
ERJ Open Research|March 18, 2026
Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosisWim A Wuyts, Francesco Bonella, Haruyuki Ishii, et al.
Respiratory Research|July 20, 2019
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV<sub>1</sub>David M G Halpin, Eli O Meltzer, Wendelgard Pisternick-Ruf, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Allergy and Clinical Immunology. in Practice|November 28, 2017
Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 PhenotypeThomas B Casale, Eric D Bateman, Mark Vandewalker, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|December 8, 2019
Is panendoscopy a necessary staging procedure in patients with lacking risk factors and oral squamous cell carcinoma?Karl Metzger, Dominik Horn, Timo Pfeiffer, et al.
Clinical Oral Investigations|March 26, 2024
Second primary squamous cell carcinoma of the oral cavity - a retrospective cohort study of therapeutic procedures and oncological outcomeJulius Moratin, Theresa Maas, Dominik Horn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2015
Shape control and compartmentalization in active colloidal cellsMatthew Spellings, Michael Engel, Daphne Klotsa, et al.
Respiratory Medicine|August 6, 2016
Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic statusHuib A M Kerstjens, Petra Moroni-Zentgraf, Donald P Tashkin, et al.
ACS Nano|October 18, 2022
Quinary, Senary, and Septenary High Entropy Alloy Nanoparticle Catalysts from Core@Shell Nanoparticles and the Significance of Intraparticle HeterogeneitySandra L A Bueno, Alberto Leonardi, Nabojit Kar, et al.
Nature Communications|October 7, 2018
Graphene-enabled and directed nanomaterial placement from solution for large-scale device integrationMichael Engel, Damon B Farmer, Jaione Tirapu Azpiroz, et al.
The Journal of Allergy and Clinical Immunology|February 13, 2017
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthmaStanley J Szefler, Kevin Murphy, Thomas Harper, et al.
ERJ Open Research|March 18, 2026
Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosisWim A Wuyts, Francesco Bonella, Haruyuki Ishii, et al.
Respiratory Research|July 20, 2019
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV<sub>1</sub>David M G Halpin, Eli O Meltzer, Wendelgard Pisternick-Ruf, et al.
Pageof 23